Related Experiment Video
Updated: May 13, 2026
07:40
A Model of Self-limited Acute Lung Injury by Unilateral Intra-bronchial Acid Instillation
Published on: August 30, 2019
[Aspirin-exacerbated respiratory disease].
1Institut für Pneumologie an der Universität Witten/Herdecke, Klinik für Pneumologie und Allergologie, Zentrum für Schlaf- und Beatmungsmedizin, Krankenhaus Bethanien, Solingen, Germany. randerath@klinik-bethanien.de
Deutsche Medizinische Wochenschrift (1946)
|March 7, 2013
Summary
Aspirin sensitivity, or Aspirin-Exacerbated Respiratory Disease (AERD), is a metabolic disorder, not an allergy. Aspirin desensitization effectively treats nasal symptoms and can stabilize asthma in affected patients.
Area of Science:
- Immunology
- Pulmonology
- Otolaryngology
Context:
- Aspirin sensitivity, also known as Aspirin-Exacerbated Respiratory Disease (AERD), is a significant comorbidity in patients with nasal polyps, asthma, or urticaria.
- This condition primarily affects adult women, with nasal symptoms often preceding asthma and NSAID intolerance by many years.
- Nasal polyps, a common feature, frequently recur after surgical removal, and the associated asthma is often difficult to manage, necessitating oral steroid treatment.
Purpose:
- To elucidate the underlying mechanisms of aspirin sensitivity, distinguishing it from allergic reactions.
- To highlight the diagnostic standards and therapeutic approaches for AERD.
- To emphasize the metabolic basis of NSAID sensitivity and the role of cysteinyl leukotrienes.
Summary:
- Aspirin sensitivity (AERD) is characterized by chronic rhinosinusitis, nasal polyps, asthma, and acute reactions to NSAIDs, stemming from a metabolic disorder involving leukotriene overexpression, not IgE-mediated allergy.
- Diagnosis relies on provocation testing, as skin tests and specific antibodies are negative.
- Aspirin desensitization is a key therapy, improving nasal symptoms and potentially stabilizing asthma.
Impact:
- Provides a clearer understanding of AERD as a metabolic disorder, guiding diagnostic and therapeutic strategies.
- Highlights the limitations of traditional allergy testing for AERD.
- Establishes aspirin desensitization as a valuable treatment option for improving patient outcomes in AERD.
Related Concept Videos
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:24Asthma-III: Symptoms and Complications
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...